Tulgar and Senturk (50) |
2018 |
Patient |
Bupivacaine 0.25% + lidocaine 0.3% |
30 ml |
L4 |
T12-L4 |
6 |
Chung and Kim (51) |
2018 |
Patient |
5 ml 2% lidocaine and 15 ml contrast medium |
20 ml |
L4 |
L2-S1 |
4 |
De Lara González et al (47) |
2019 |
Corpse |
Contrast medium |
20 ml |
L4 |
L2-L5 |
5 |
Mantuani et al (52) |
2019 |
Patient |
20 ml of 1% lidocaine containing adrenaline |
20 ml |
L1 |
T10-L2 |
4 |
Celik et al (53) |
2019 |
Patient |
40 ml injection, including 20 ml bupivacaine, 10 ml lidocaine, 8.6 ml physiological saline, 40 mg/ml methylprednisolone, 1 ml, and 0.4 ml contrast agent |
40 ml |
L4 |
L1-S4 |
4.4 |
Ahiskalioglu et al (54) |
2020 |
Patient |
20 ml 0.5% bupivacaine, 10 ml 2% lidocaine, and 10 ml physiological saline |
20 ml |
L4 |
L2-L5 |
5 |
Breidenbach et al (55) |
2023 |
Corpse |
1 ml methylene blue and 19 ml 0.25% bupivacaine |
20 ml |
L4 |
L2-S1 |
4 |
Zhang et al (56) |
2021 |
Patient |
20 ml 0.4% ropivacaine |
20 ml |
L3 |
L1-L5 |
4 |
Yi-Han et al (21) |
2022 |
Patient |
20 ml 0.375% ropivacaine and 20 ml dexmedetomidine |
20 ml |
L3 |
L1-L5 |
4 |